Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Chronic diarrhea with villous atrophy is a rare, genetic gastroenterological disease characterized by the early onset of chronic diarrhea, vomiting, anorexia, lactic acidosis, renal insufficiency and hepatic involvement (mild elevation of liver enzymes, steatosis, hepatomegaly). Partial villous atrophy (with eosinophilic infiltration) is observed on intestinal biopsy. Although diarrhea may resolve, the development of neurologic symptoms (cerebellar ataxia, sensorineural deafness, seizures), retinitis pigmentosa and muscle weakness may complicate disease course and lead to death. There have been no further descriptions in the literature since 1994.
Biomarker and diagnostic research for chronic diarrhea with villous atrophy has been reported in the published literature.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
No clinical trials have been registered for chronic diarrhea with villous atrophy.
27 publications have been identified in PubMed for chronic diarrhea with villous atrophy. Research spans Case Report / Case Series (70%), Review / Meta-Analysis (22%), and Diagnostic / Biomarker (4%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 19 | 70% |
Data assembled from 4 of 12 sources · Last updated Sep 19, 2026, 6:58 PM UTC
Online Mendelian Inheritance in Man
European rare disease database
Genetic and Rare Diseases Info Center
Common questions about chronic diarrhea with villous atrophy
Research summaries
6 |
22% |
Testing and diagnosis research | 1 | 4% |
Disease patterns and progression | 1 | 4% |
Manu LM (2026). [PMID: 42199680](https://pubmed.ncbi.nlm.nih.gov/42199680/). *Trop Parasitol*. [Epidemiology / Natural History]
Hrouch W (2026). [PMID: 41798567](https://pubmed.ncbi.nlm.nih.gov/41798567/). *Cureus*. [Case Report / Case Series]
Ortiz-Prado E (2026). [PMID: 41656249](https://pubmed.ncbi.nlm.nih.gov/41656249/). *Gut Pathog*. [Review / Meta-Analysis]
Gupta V (2026). [PMID: 41957649](https://pubmed.ncbi.nlm.nih.gov/41957649/). *J Med Case Rep*. [Case Report / Case Series]
Stirrat T (2026). [PMID: 41854086](https://pubmed.ncbi.nlm.nih.gov/41854086/). *Scand J Gastroenterol*. [Review / Meta-Analysis]
Khan MA (2026). [PMID: 41982449](https://pubmed.ncbi.nlm.nih.gov/41982449/). *VideoGIE*. [Review / Meta-Analysis]
Nikolaeva A (2026). [PMID: 41952938](https://pubmed.ncbi.nlm.nih.gov/41952938/). *Cureus*. [Case Report / Case Series]
Thakkar B (2026). [PMID: 42158908](https://pubmed.ncbi.nlm.nih.gov/42158908/). *ACG Case Rep J*. [Case Report / Case Series]
Stoeckli L (2025). [PMID: 40487080](https://pubmed.ncbi.nlm.nih.gov/40487080/). *Case Rep Gastroenterol*. [Case Report / Case Series]
Li M (2025). [PMID: 40622608](https://pubmed.ncbi.nlm.nih.gov/40622608/). *Clin Rheumatol*. [Case Report / Case Series]